Waging War Against Chronic Myeloid Leukemia
A possible new front runner is emerging in the drug war against chronic myeloid leukemia ( CML ). While still considered experimental, this drug is showing itself to be a powerful agent against advanced forms of the disease.
Unlocking Chronic Myeloid Leukemia Resistance
Gleevec ( imatinib ) has transformed the treatment of chronic myeloid leukemia ( CML ). The problem is, this drug stops working at some point in many patients. A drug under development, combined with another currently available medication, may offer patients new options.
It doesn't happen commonly, though some diseases can present themselves as other diseases. Scientists now know this sometimes happens with two forms of leukemia.
Merck Announces Multiple Myeloma Drug Trial Results
Merck announced today that a Phase III study of Zolinza ( vorinostat ), for investigational use in combination with bortezomib in patients with progressive multiple myeloma , met its primary endpoint, demonstrating a 23 percent reduction in the risk of progression compared to the standard therapy of bortezomib (p=0.01).
Two Sisters Help Understand One Disease
It's well known that cancer can be passed between a donor and recipient during a transplant operation. One such exchange has actually advanced the scientific understanding of lymphoma.
Stem Cell Transplant Recipients Prone to Problems
Stem cell transplant patients may not only be at risk during treatment. A new study suggests that a decade later they are still more susceptible to psychological conditions and chronic illness.
New Lymphoma Bull's-Eye
It's the most aggressive blood cancer. Unfortunately, Diffuse Large B-Cell Lymphoma ( DLBCL ) is also the most common form of lymphoma in adults. But there is some good news - researchers may have a new target for treating this disease.
Which is Better for Chronic Myeloid Leukemia?
Chronic Myeloid Leukemia ( CML ) has some amazing treatment options for patients. The disease has proven to respond well to three drugs known as tyrosine kinase inhibitors. An ongoing trial is looking to see which of two of these drugs is most effective.
Improving Chronic Myeloid Leukemia Treatment
Since its introduction some years ago, Gleevec ( imatinib ) has been the drug of choice for treating patients newly diagnosed with chronic myeloid leukemia ( CML ).
Stem Cells Age Too
Everything ages over time. And human stem cells are no exception. Understanding this aging process may help explain why the elderly are more susceptible to infections and certain cancers.